Education
About Us
Working with TipRanks
Follow Us
Coelho Rogerio Vivaldi Insider Profile
11 Followers
Coelho Rogerio Vivaldi, CCO at Spark Therapeutics, holds 21.69K shares in Viatris (Ticker: VTRS), holds 14.40K shares in Crinetics Pharmaceuticals (Ticker: CRNX), holds 0.00 shares in Sigilon Therapeutics (Ticker: SGTX).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+21.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Coelho Rogerio Vivaldi holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 09, 2023 - Jun 09, 2024
Return:+106.30%
The most profitable trade made by Coelho Rogerio Vivaldi
Coelho Rogerio Vivaldi's Trading History
Spark Therapeutics
Oct 14, 2015
―
Uninformative Sell
1.16M
$2.13M
Bioverativ Inc
Mar 08, 2018
―
Uninformative Sell
―
$0.00
Sigilon Therapeutics
Aug 11, 2023
―
Uninformative Sell
―
$0.00
Crinetics Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
―
$479.23K
Viatris
Mar 05, 2025
Director
Uninformative Buy
203.24K
$209.32K
Minerva Neurosciences
Jul 09, 2014
President & CEO, Director
Informative Buy
250.00K
$68.33K
List of latest transactions for each holding click on a transaction to see Coelho Rogerio Vivaldi's performance on stock
You May Also Like
Coelho Rogerio Vivaldi insider profile FAQ
What is the percentage of profitable transactions made by Coelho Rogerio Vivaldi?
The percentage of profitable transactions made by Coelho Rogerio Vivaldi is 50%.
What is the average return per transaction made by Coelho Rogerio Vivaldi?
The average return per transaction made by Coelho Rogerio Vivaldi is 21.20%.
What stocks does Coelho Rogerio Vivaldi hold?
Coelho Rogerio Vivaldi holds: ONCE, BIVV, SGTX, CRNX, VTRS, NERV stocks.
What was Coelho Rogerio Vivaldi’s latest transaction?
Coelho Rogerio Vivaldi latest transaction was an Uninformative Buy of $203.24K.
What was Coelho Rogerio Vivaldi's most profitable transaction?
Coelho Rogerio Vivaldi’s most profitable transaction was an Informative Buy of CRNX stock on June 9, 2023. The return on the trade was 106.30%.
What is Coelho Rogerio Vivaldi's role in Spark Therapeutics?
Coelho Rogerio Vivaldi's role in Spark Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.